Conjugation of Phthalocyanine Photosensitizer with Poly(amidoamine) Dendrimer: Improved Solubility, Disaggregation and Photoactivity Against HepG2 Cells

Author(s): Zhou Jiang, Jiqing Ye, Jingyi Yang, Jian Wang*, Lee Jia*, Rodney JY Ho.

Journal Name: Current Cancer Drug Targets

Volume 19 , Issue 4 , 2019

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer

Graphical Abstract:


Objective: To improve solubility and to reduce aggregation, ZnPcC4 was conjugated to a third-generation poly-amidoamine dendrimer with amino end group (G3-PAMAM-NH2), which acts as a novel photodynamic therapy (PDT) drug carrier system.

Methods: The phthalocyanines were synthesized by construction reaction. The nano drug was obtained from the conjugation of ZnPcC4 to G3-PAMAM-NH2, using EDC and NHS as coupling agents. The ZnPcC4@G3-PAMAM-NH2 conjugation was characterized by UV-Vis and MS. The 1O2 quantum yield of ZnPcC4@G3-PAMAM-NH2 in water was measured by the chemiluminescence method. The in vitro PDT responses of the studied photosensitizers were studied in hepatocellular carcinoma cell line HepG2 by MTT assay.

Results: At ZnPcC4/G3-PAMAM-NH2 raw ratio of 100/1, the ZnPcC4 conjugate had improved solubility and reduced aggregation tendency in aqueous solution. At this optimum molar ratio, ZnPcC4- G3-PAMAM-NH2 inhibited HepG2 cells, with a half-maximal inhibitory concentration of 1.67 µg/mL upon infrared light exposure. The controls, including dark conditions, or media as well as G3-PAMAM-NH2 exposure, exhibited no inhibitory response.

Conclusion: The conjugation of phthalocyanine photosensitizer ZnPcC4 to poly-amidoamine dendrimer G3-PAMAM-NH2 improved the PDT outcomes, in which the optimized binding ratio of ZnPcC4 to G3-PAMAM-NH2 was 6:1.

Keywords: Poly(amidoamine) dendrimer, tetra-carboxyl phthalocyaninato zinc, HepG2 cells, photodynamic therapy, reactive oxygen species, hepatocellular carcinoma.

Brown, S.B.; Brown, E.A.; Walker, I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol., 2004, 5(8), 497-508.
Dichiara, M.; Prezzavento, O.; Marrazzo, A.; Pittala, V.; Salerno, L.; Rescifina, A.; Amata, E. Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents. Eur. J. Med. Chem., 2017, 142, 459-485.
Yeung, H.Y.; Lo, P.C.; Ng, D.K.; Fong, W.P. Anti-tumor immunity of bam sipc-mediated vascular photodynamic therapy in a balb/c mouse model. Cell. Mol. Immunol., 2017, 14, 223-234.
Milla Sanabria, L.; Rodriguez, M.E.; Cogno, I.S.; Rumie Vittar, N.B.; Pansa, M.F.; Lamberti, M.J.; Rivarola, V.A. Direct and indirect photodynamic therapy effects on the cellular and molecular components of the tumor microenvironment. Biochim. Biophys. Acta, 2013, 1835(1), 36-45.
Macdonald, I.J.; Dougherty, T.J. Basic principles of photodynamic therapy. J. Porphyr. Phthalocyanines, 2001, 5(02), 105-129.
Jiang, Z.; Shao, J.; Yang, T.; Wang, J.; Jia, L. Pharmaceutical development, composition and quantitative analysis of phthalocyanine as the photosensitizer for cancer photodynamic therapy. J. Pharm. Biomed. Anal., 2014, 87, 98-104.
Shao, J.; Xue, J.; Dai, Y.; Liu, H.; Chen, N.; Jia, L.; Huang, J. Inhibition of human hepatocellular carcinoma HepG2 by phthalocyanine photosensitiser Photocyanine: ROS production, apoptosis, cell cycle arrest. Eur. J. Cancer, 2012, 48(13), 2086-2096.
Shao, J.; Dai, Y.; Zhao, W.; Xie, J.; Xue, J.; Ye, J.; Jia, L. Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II) phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells. Cancer Lett., 2013, 330(1), 49-56.
Ishii, K. Functional singlet oxygen generators based on phthalocyanines. Coord. Chem. Rev., 2012, 256(15-16), 1556-1568.
Jia, X.; Jia, L. Nanoparticles improve biological functions of phthalocyanine photosensitizers used for photodynamic therapy. Curr. Drug Metab., 2012, 13, 1119-1122.
Gao, Y.; Xie, J.J.; Chen, H.J.; Gu, S.G.; Zhao, R.L.; Shao, J.W.; Jia, L. Nanotechnology-based intelligent drug design for cancer metastasis treatment. Biotechnol. Adv., 2014, 32, 761-777.
Spyropoulos-Antonakakis, N.; Sarantopoulou, E.; Stefi, A.L.; Kollia, Z.; Gariil, V.E.; Bourkoula, A.; Petrou, P.S.; Kakabakos, S.; Semashko, W.; Niamutdinov, A.S.; Cefalas, A.C. Selective aggregation of PAMAM dendrimer nanocariers and PAMAM/ZnPc nanodrugs on human atheromatous carotid tissues: A photodynamic therapy for atherosclerosis. Nanoscale Res. Lett., 2015, 10, 210.
Zhang, X.F.; Xi, Q.A.; Zhao, J. Fluorescent and triplet state photoactive J-type phthalocyanine nano assemblies: Controlled formation and photosensitizing properties. J. Mater. Chem., 2010, 20(32), 6726-6733.
Xie, J.J.; Zhao, R.L.; Gu, S.E.; Dong, H.Y.; Wang, J.C.; Lu, Y.S.; Sinko, P.J.; Yu, T.; Xie, F.W.; Wan, L.; Shao, J.W.; Jia, L. The architecture and biological function of dual antibody-coated dendrimers: Enhanced control of circulating tumor cells and their hetero-adhesion to endothelial cells for metastasis prevention. Theranostics, 2014, 4, 1250-1263.
Liang, X.J.; Meng, H.; Wang, Y.Z.; He, H.Y.; Meng, J.; Lu, J.; Wang, P.C.; Zhao, Y.L.; Gao, X.Y.; Sun, B.Y.; Chen, C.Y.; Xing, G.M.; Shen, D.W.; Gottesman, M.M.; Wu, Y.; Yin, J.J.; Jia, L. Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis. Proc. Natl. Acad. Sci. , 2010, 107, 7449-7454.
Wang, J.; Jiang, Z.; Chen, N.S.; Huang, J.L. Investigation of photoinduced sensitized chemiluminescence by sulfonated phthalocyanines using flow injection technology. Mikrochim. Acta, 2006, 153(1-2), 79-85.
Zhang, X.F.; Qian, X.; Zhao, J. Fluorescent and triplet state photoactive J-type phthalocyanine nano assemblies: Controlled formation and photosensitizing properties. J. Mater. Chem., 2010, 20, 6726-6733.
Spiller, W.; Kliesch, H.; Wöhrle, D.; Hackbarth, S.; Röder, B.; Schnurpfeil, G. Singlet oxygen quantum yields of different photo-sensitizers in polar solvents and micellar solutions. J. Porphyr. Phthalocyanines, 1998, 2(2), 145-158.
Shinohara, H.; Tsaryova, O.; Schnurpfeil, G.; Wöhrle, D. Differently substituted phthalocyanines: Comparison of calculated energy levels, singlet oxygen quantum yields, photo-oxidative stabilities, photocatalytic and catalytic activities. J. Photochem. Photobiol. Chem., 2006, 184(1), 50-57.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Page: [312 - 320]
Pages: 9
DOI: 10.2174/1568009618666180706164046
Price: $58

Article Metrics

PDF: 28